London Stock Exchange International Order Book (IOB) enables investors to unlock the potential of some of the world’s fastest growing markets through a single central electronic order book. It offers easy, cost-efficient and direct access to securities via global depositary receipts (GDRs) from over 30 countries, including markets in Central and Eastern Europe, Asia and the Middle East. The market has grown rapidly since its inception in 2001, with Gazprom, Sberbank and Lukoil among the most heavily traded securities on London Stock Exchange.
Shanghai-London Stock Connect GDRs or underlying equity are traded on IOB Shanghai Segment.
Today London Stock Exchange markets were opened by HSBC Global Asset Management to celebrate the listings of their suite of seven Sustainable Equity ETFs.
HSBC Asia Pacific ex Japan Sustainable Equity UCITS ETF
HSBC Developed World Sustainable Equity UCITS ETF
HSBC Emerging Market Sustainable Equity UCITS ETF
HSBC Europe Sustainable Equity UCITS ETF
Today the London Stock Exchange markets were opened by J.P. Morgan Asset Management (JPMAM) to celebrate the launch of JPMorgan Carbon Transition Global Equity UCITS ETF (ticker: JPCT), a sustainable ETF which offers core exposure to global equities with a low tracking error, compared to the MSCI World Index, and have a meaningful reduction in carbon intensity.
JPCT will track the JPM
Sasha Wiggins, Group Head of Public Policy and Corporate Responsibility at Barclays this morning opened the market at London Stock Exchange in recognition of the listing of the bank’s second Green Bond. The bond was listed on Tuesday 3 November, raising £400m to support the development of Barclays’ Green Mortgages portfolio.
Commenting on the Green Bond issuance Sasha Wiggins, Group H
London Stock Exchange welcomes Verici Dx plc (‘Verici Dx’ or the ‘Company’), a developer of advanced clinical diagnostics for organ transplant, to celebrate the listing of the Company's public shares onto AIM, under the ticker "VRCI".
Verici Dx is an immuno-diagnostics development company, initially focused on the kidney transplantation market. The Company's kidney transplant